Gene · 8317
NIH grants1,079
NIH grants whose papers are about the gene, through NIH's grant-paper links.
381 to 400 of 1,079
Download this page as JSON| Grant | Title | CDC7 papers | Newest fiscal year |
|---|---|---|---|
| K08HL136928 | Multi-omic Subtyping of Chronic Obstructive Pulmonary Disease | 1 | 2021 |
| K99CA248953 | Identifying drug synergistic with cancer immunotherapy | 1 | 2021 |
| P01AG017586 | Frontotemporal Dementias: Genotypes and Phenotypes | 1 | 2021 |
| P01CA042063 | Characterization of Pathways Controlling Cancer at the Level of Gene Regulation | 1 | 2021 |
| P01CA203655 | Human Cancer Suppressor Functions of Protein Phosphatase 2A | 1 | 2021 |
| P41GM103533 | Comprehensive Biology: Exploiting the Yeast Genome | 1 | 2021 |
| P50AR060780 | Translational studies for identifying and targeting novel pathways in systemic sclerosis pathogenesis | 1 | 2021 |
| R01AI127562 | Molecular dynamics of genome and epigenome integrity in Trypanosoma brucei | 1 | 2021 |
| R01AR049069 | Molecular Control of Bone Formation | 1 | 2021 |
| R01CA105304 | Delineating the mechanisms of androgen receptor activation function-1 antagonists for development of novel prostate cancer therapeutics | 1 | 2021 |
| R01CA148629 | Novel approaches to enhance tumor cell cytotoxicity of alkylating agents | 1 | 2021 |
| R01CA212518 | Kinase signaling during mammary tumor initiation | 1 | 2021 |
| R01CA213912 | Targeting CK2 oncogenic pathway to overcome drug resistance in high-risk leukemia | 1 | 2021 |
| R01CA215067 | The structural function of ATR in development, oncogenesis and cancer therapy | 1 | 2021 |
| R01CA215075 | Immune Regulation of Lung Squamous Metastasis | 1 | 2021 |
| R01CA229739 | Development of small molecules to target KDM4B | 1 | 2021 |
| R01ES014811 | A Systems Approach to Mapping the DNA Damage Response | 1 | 2021 |
| R01GM026132 | Mechanism of cytokinesis in fission yeast | 1 | 2021 |
| R01GM080670 | The Rtt107 interactome structures and functions | 1 | 2021 |
| R01GM123313 | Dissecting the interplay of gene regulatory networks and cellular niche on cell fate determination | 1 | 2021 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8317/grants?page=20